Fractyl’s Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 25 Oct, 12:30 UTC

Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares of Fractyl stock dropped steeply on October 16 immediately following the announcement. Despite the positive findings, the stock’s sharp decline highlighted a contrast between…

businessscience

Sources

• T2Fractyl’s Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs FollowFierce Biotech / Fierce Healthcare / MedCity / GEN25 Oct, 12:30